Surprisingly, this relationship also extended to those below the threshold for controlled T2DM, i.e., HbA1c between 5 and 6.9%
However, fat oxidation rates were lower than predicted from GH elevation alone, likely because continuous GH suppresses insulin sensitivity more than pulsatile patterns
Three Evidence-Based Strategies to Restart Weight Loss Dose escalation is the most direct approach if your prescriber determines it's appropriate
Body composition analysis with InBody provides: Accurate BMR measurement for personalised nutrition planning during GLP-1 therapy Visceral fat assessment for metabolic disease risk evaluation at each visit Muscle mass tracking to prevent metabolic slowdown and sarcopenia Phase angle monitoring for cellular health across the treatment course Water distribution analysis for detecting inflammation and fluid imbalance This comprehensive metabolic assessment is alone, and it is now the clinical standard of care in progressive metabolic medicine globally
Food and Drug Administration has approved GLP-1 therapies for managing type 2 diabetes and for treating obesity
The first GLP-1 drug was approved for type 2 diabetes back in 2005, and the class remains highly effective at lowering blood sugar